Evidence map›Paper›PMID 29117323›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?

Joy E Lawn, Fiorella Bianchi-Jassir, Neal J Russell, Maya Kohli-Lynch, Cally J Tann, Jennifer Hall, Lola Madrid, Carol J Baker, Linda Bartlett, Clare Cutland and 11 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06833957 (PReparing for OptimalPhase III/IV maTErnal Group B StreptococCal Vaccine Trials in Africa), which is not on this map. Cited by 71 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 14 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06833957 recruitingnot on this mapstarted 2025, after this paper: background citation

PReparing for OptimalPhase III/IV maTErnal Group B StreptococCal Vaccine Trials in Africa (PROTECT)

Typeobservational_patient_registrySponsorBarcelona Institute for Global HealthRan2025 to 2027Enrolled18,100ConditionsGroup B Streptococcus, Invasive Bacterial Diseases (IBD), Maternal Immunization
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 14 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  7. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  8. Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  9. Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  10. Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  11. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  12. Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  13. Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  14. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Review
  20. Maternal Group BClinical epidemiology · 2026
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 18 institutions in 8 countries.

Joy E LawnMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Fiorella Bianchi-JassirMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Neal J RussellMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Maya Kohli-LynchMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Cally J TannMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Jennifer HallDepartment of Reproductive Health Research, University College London Institute for Women's Health, United Kingdom.
Lola MadridMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Carol J BakerDepartments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
Linda BartlettDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Clare CutlandMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Michael G GravettGlobal Alliance to Prevent Prematurity and Stillbirth.
Paul T HeathVaccine Institute, Institute for Infection and Immunity, St George's Hospital, University of London and St George's University Hospitals NHS Foundation Trust, United Kingdom.
Margaret IpDepartment of Microbiology, Faculty of Medicine, Chinese University of Hong Kong.
Kirsty Le DoareVaccine Institute, Institute for Infection and Immunity, St George's Hospital, University of London and St George's University Hospitals NHS Foundation Trust, United Kingdom.
Shabir A MadhiMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Craig E RubensGlobal Alliance to Prevent Prematurity and Stillbirth.
Samir K SahaBangladesh Institute of Child Health, Dhaka.
Stephanie SchragNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ajoke Sobanjo-Ter MeulenBill & Melinda Gates Foundation, Seattle, Washington.
Johan VekemansWorld Health Organization, Geneva, Switzerland.
Anna C SealeMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
London School of Hygiene & Tropical Medicine · GBSt George's Hospital · GBBaylor College of Medicine · USBill & Melinda Gates Foundation · USCenters for Disease Control and Prevention · USChild Health Research Foundation · BDChinese University of Hong Kong · CNGlobal Alliance to Prevent Prematurity and Stillbirth · USHaramaya University · ETJohns Hopkins University · USNational Health Laboratory Service · ZAUniversitat de Barcelona · ESUniversity College London · GBUniversity College London Hospitals NHS Foundation Trust · GBUniversity of Bristol · GBUniversity of the Witwatersrand · ZAUniversity of Washington · USWorld Health Organization · CH

Funding

Wellcome Trust 205184/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

Improving maternal, newborn, and child health is central to Sustainable Development Goal targets for 2030, requiring acceleration especially to prevent 5.6 million deaths around the time of birth. Infections contribute to this burden, but etiological data are limited. Group B Streptococcus (GBS) is an important perinatal pathogen, although previously focus has been primarily on liveborn children, especially early-onset disease. In this first of an 11-article supplement, we discuss the following: (1) Why estimate the worldwide burden of GBS disease? (2) What outcomes of GBS in pregnancy should be included? (3) What data and epidemiological parameters are required? (4) What methods and models can be used to transparently estimate this burden of GBS? (5) What are the challenges with available data? and (6) How can estimates address data gaps to better inform GBS interventions including maternal immunization? We review all available GBS data worldwide, including maternal GBS colonization, risk of neonatal disease (with/without intrapartum antibiotic prophylaxis), maternal GBS disease, neonatal/infant GBS disease, and subsequent impairment, plus GBS-associated stillbirth, preterm birth, and neonatal encephalopathy. We summarize our methods for searches, meta-analyses, and modeling including a compartmental model. Our approach is consistent with the World Health Organization (WHO) Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER), published in The Lancet and the Public Library of Science (PLoS). We aim to address priority epidemiological gaps highlighted by WHO to inform potential maternal vaccination.

Indexed as

Cost of IllnessStreptococcus agalactiaeChildFemaleHumansModels, StatisticalPregnancyPregnancy Complications, InfectiousPregnancy OutcomeRisk FactorsStillbirthStreptococcal InfectionsStreptococcal VaccinesStreptococcal Vaccinesglobal burdengroup B Streptococcusmaternalneonatalstillbirth

Identifiers

PMID29117323
PMCPMC5850012
OpenAlexW2767490364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.